The integration of Accu-Chek SmartGuide's AI-enabled predictive CGM with the popular mySugr app delivers a simple, intuitive solution for people to manage their diabetes with greater ease. Accu-Chek ...

Roche Holding RHHBY recently announced that it has received the CE Mark for its Accu-Chek SmartGuide continuous glucose monitoring (CGM) solution. With the approval, CGM solution can now be made ...

Health Canada has issued a recall for some Accu-Chek Guide devices due to inaccurate blood glucose readings. Certain units of the medical measurement device incorrectly display blood glucose levels, ...

BASEL, Switzerland, Sept. 16, 2025 /PRNewswire/ -- Roche (SIX: RO, ROG; OTCQX: RHHBY) shared real-world evidence from the rollout of Accu-Chek SmartGuide continuous glucose monitoring (CGM) solution ...

(RTTNews) - Astellas Pharma Inc. said that it has reached an agreement with Roche Diabetes Care Japan Co., Ltd. for the development and commercialization of Roche Diabetes Care's Accu-Chek Guide Me ...

Roche receives CE Mark for Accu-Chek SmartGuide Continuous Glucose Monitoring and mySugr App integration, offering an enhanced diabetes management experience The integration of Accu-Chek SmartGuide's ...

- Accu-Chek ® Guide Me glucose meter to be paired with BlueStar ® in Japan, which is being jointly developed by Astellas and Welldoc - - Initiation of clinical trial planned for fiscal year 2023 - ...

First diabetes data management platform outside of Roche’s ecosystem to integrate with Accu-Chek SmartGuide CGM, bringing more choice and a more complete view of data to people with diabetes and their ...